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Received February 1, 2016; accepted March 25, 2016AbstractBackground: Medical abortion that occurs in early pregnancy is generally safe and successful, but incomplete medical abortion can result in
complications. This study aimed to examine factors related to completeness of medical abortion with mifepristone and misoprostol, and then to
provide a new direction for research into establishing complete abortion with mifepristone and misoprostol.
Methods: Sixty-three patients with early pregnancy requesting medical abortion with mifepristone and misoprostol were selected. Immuno-
histochemistry was used to detect the expression and location of progesterone receptor, estrogen receptor, insulin-like growth factor-1, and
vascular endothelial growth factor in chorionic villi among these women. Reverse transcriptase polymerase chain reaction was then used to
determine the expression of insulin-like growth factor-1 and vascular endothelial growth factor mRNA.
Results: According to the outcome of medical abortion, the women were divided into either the incomplete medical abortion group (n¼ 34) or
the complete medical abortion group (n¼ 29). Immunohistochemical analysis showed that progesterone receptor and estrogen receptor protein
expression was not detected in chorionic villi in the two groups. However, compared with the complete abortion group, there was a marked
decrease in the expression of insulin-like growth factor-1 and a significant increase in the expression of vascular endothelial growth factor
( p< 0.05) in the incomplete abortion group. There was no significant difference in mRNA expression between the incomplete and complete
abortion groups.
Conclusion: The expression of insulin-like growth factor 1 protein and vascular endothelial growth factor protein in chorionic villi may be
related to the outcome of medical abortion with mifepristone and misoprostol.
Copyright © 2016, the Chinese Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction first approved medication for medical abortion. Actually,Recently, medical termination has been the first choice for
early pregnancy termination, and > 50% of the 53 million
women with unwanted pregnancy worldwide requesting
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).mifepristone in combination with misoprostol is safe and
effective, has been used formore than 2 decades, and is available
in 35 countries.2 Mifepristone and misoprostol, in combination,
generally demonstrate a high complete abortion rate of
92e99%.3 However, the commonest causes of failure of this
method are incomplete abortion (5%), excessive bleeding (3%),
and ongoing pregnancy (1%).4,5 Incomplete abortion commonly
causes hemorrhage, infection, and abdominal pain, and has the
potential for long-term emotional consequences. Furthermore,
the risk of vaginal bleeding during medical abortion with
mifepristone and misoprostol is increased in the early period of
pregnancy.6 Thus, it is important to findparameters to predict theness of medical abortion with mifepristone and misoprostol, Journal of the
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been suggested for the evaluation of the outcome of medical
abortion, such as endometrial thickness determined by ultra-
sound7 and serum beta-human chorionic gonadotropin mea-
surement.8 However, none of these clinical factors are highly
accurate or reliable.8e11 At a molecular level, prolonged
bleeding after medical abortion with mifepristone and miso-
prostol is associated with elevated expression levels of matrix
metalloproteinase-9 (MMP-9) in villi and of tissue inhibitors of
metalloproteinases-2 (TIMP-2) in the decidua.12 However, no
research has been carried out focusing on villi to study the
success of medical abortion. Hence, we decided to explore
factors in chorionic villi to relate the success ofmedical abortion
with mifepristone and misoprostol.
Mifepristone functions as an antiprogesterone by competing
with progesterone in the endometrium and decidua for receptor
binding, thus terminating early pregnancy.13 An array of novel
progesterone receptor (PR)-regulated gene pathways and high
expression of PR were found in the decidua of pregnant mice
treated with mifepristone,14 indicating that progesterone may
play important roles in the regulation of endometrial decidu-
alization, which can be blocked bymifepristone. However, only
limited information is available about the effect of mifepristone
in early gestational chorionic villi. One study reported that
mifepristone impaired the production of human placental lac-
togen and progesterone in cultured syncytiotrophoblasts,15 but
there have been no published reports studying the correlation
between PR in human chorionic villi and the outcome of
medical abortion with mifepristone and misoprostol.
Progesterone, estrogen, and their receptors can be modu-
lated by each other, and are responsible for physiological
changes of the endometrium and also essential for the main-
tenance of pregnancy and development of embryo. As early as
1975, Hsueh et al16 showed that progesterone can decrease the
sensitivity of tissue to estrogen by acting on the cytoplasmic
estrogen receptor (ER) to decrease the quantity of uterine ER.
Decreased ER alpha, ER beta, and PR-B levels in the human
endometrium may be related to prolonged uterine bleeding
after medical abortion by mifepristone accompanied by
misoprostol.17 Therefore, some investigators proposed that
downregulation of ER was also related to the outcome of
medical abortion; such a proposition, however, completely
focuses on the endometrium.
Many other factors such as insulin-like growth factor 1
(IGF-1) and vascular endothelial growth factor (VEGF),18,19
are thought to contribute to the development of human em-
bryos and to be related to the outcome of medical abortion.
Antiestrogen tamoxifen may inhibit the growth of leiomyoma
by interrupting an IGF-1 autocrine loop in the leiomyoma cell
lines.20 Animal experiments have established that the VEGF
mRNA and protein can be upregulated by ER and PR,
contributing to vasculogenesis and embryo development.18
Studies about IGF-1 and VEGF are mostly carried out on
leiomyoma and endometriosis, and there are few reports
evaluating the roles of IGF-1 and VEGF in chorionic villi in
medical abortion with mifepristone and misoprostol. Hence,
IGF-1 and VEGF, which were hypothesized to be relatedPlease cite this article in press as: Jiang W-X, et al., Factors related to complete
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were also investigated using immunohistochemistry and
reverse transcriptase polymerase chain reaction (RT-PCR) in
chorionic villi tissues from women undergoing abortion.
In the present study, the relationship between ER, PR, IGF-
1, and VEGF expression in chorionic villi and the outcome of
medical abortion with mifepristone and misoprostol were
studied. In addition, whether PR, ER, IGF-1, and VEGF in
chorionic villi were related to the outcome of medical abortion
was also explored.
2. Methods2.1. PatientsBetween March 2009 and April 2011, 89 women with early
pregnancy requesting medical abortion for termination of
pregnancy at The Second Affiliated Hospital of Wenzhou
Medical University were considered for recruitment in this
prospective study. Of these 89 potential study participants, 68
provided consent for inclusion in this study (Fig. 1). All patients
were initially assessed by their provided medical history,
physical examination, urine pregnancy test, routine blood test,
electrocardiogram, liver function test, and ultrasonography. The
inclusion criteria were as follows: (1) age 18e30 years old; (2)
healthy women requesting medical abortion; (3) gestational age
35e49 days (based on the onset of the last menstrual period,
bimanual examination, and ultrasound) and a gravid 1 para
0 with a singleton intrauterine pregnancy, with the presence of
fatal heart beat being confirmed by careful ultrasound exami-
nation; and (4) women being informed of the advantages and
risks of medical abortion, and signing an agreement of consent.
The exclusion criteria were as follows: (1) complication of
pregnancy; (2) drug allergy to mifepristone or misoprostol; (3)
current use of long-term systemic steroids; (4) a medical history
of disease related to the cardiovascular system, respiratory
system, liver, kidney, or adrenal gland; (5) uncontrolled hy-
pertension, cardiovascular disease angina, or diabetes mellitus;
(6) in situ intrauterine devices; (7) pelvic inflammatory disease;
(8) hemoglobin <80 g/L; (9) breastfeeding; (10) addiction to
alcohol or smoking; and (11) lost to follow-up. The study
protocol was approved by the Research Ethical Committee of
The Second Affiliated Hospital of Wenzhou Medical Univer-
sity, Wenzhou, Zhejiang, China (20090103) and met the stan-
dards of the Declaration of Helsinki. Written consent was
obtained from patients before the collection of samples.2.2. Administration and efficacyThe method and dose administration of medicine followed
the recommendation of the study of Zhuang et al.12 All appli-
cants were treated with 50 mg mifepristone administered orally
on their first visit, followed by 25 mgmifepristone administered
orally every 12 hours (total 150 mg) at home. During a second
visit 48 hours later, women received 600 mg oral misoprostol
and remained in the hospital under observation for 4 hours.
During this observation period, tissues discharged from theness of medical abortion with mifepristone and misoprostol, Journal of the
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doctors, then rinsed thoroughly in precooled phosphate-buffered
saline solution to remove excess blood, and thereafter dissected.
One-half of the tissues were fixed overnight in 4% buffered
formalin, dehydrated, and embedded in paraffin for histological
confirmation and immunohistochemistry. The other half was
frozen in liquid nitrogen and then stored at80C until use. The
observation was limited to 4 hours to ensure that all samples
were collected within this timeframe; those patients who took
longer to discharge tissuewould therefore not be included in the
successful abortion population in this study.
Follow-up visits were scheduled for 2 weeks after mife-
pristone administration to assess abortion status by means of
clinical history and ultrasound. Complete abortion was
considered as complete evacuation of the uterine contents
without a uterine aspiration procedure at any point. Incomplete
abortion was defined as contractions, pain, and vaginal
bleeding during pregnancy; an open cervical os; and some-
times partial expulsion of products of conception.21 Surgical
evacuation was indicated for continuing pregnancy, excessive
bleeding, or missed abortion, and these were considered as
failures of the medical method.2.3. ImmunohistochemistryImmunohistochemistry staining was carried out using a
standard streptavidin peroxidase method,22 on 4 mm-thick
sections from 1 cm  1 cm  0.3 cm tissue samples that
were formalin fixed and paraffin embedded. The specificPlease cite this article in press as: Jiang W-X, et al., Factors related to complete
Chinese Medical Association (2016), http://dx.doi.org/10.1016/j.jcma.2016.03.01primary antibody [antiestrogen monoclonal mouse antibody
(Maixin, Fujian, China), antiprogesterone polyclonal rabbit
antibodies (Zymed Corporation, San Francisco, CA, USA),
and anti-IGF-1 polyclonal rabbit antibodies at a dilution of
1:50 and anti-VEGF monoclonal mouse antibody at a dilution
of 1:200 (Santa Cruz Corporation, Dallas, TX, USA)] were
used, and biotinylated goat antimouse/rabbit antibody was
used as a secondary antibody, streptavidin peroxidase as a
label, and diaminobenzidine as a chromogen. The sections
were counterstained with Mayer hematoxylin to enhance nu-
clear detection. Appropriate positive and negative control
slides were stained in parallel. The negative control was
incubated with phosphate-buffered saline solution in the
absence of the primary antibody. Human leiomyomas were
taken as positive controls for PR, ER, IGF-1, and VEGF.
Under a microscope, the PR- or ER-positive cells showed
yellowish brown staining in the nucleus, and IGF-1- or VEGF-
positive cell showed yellowish brown staining in the cyto-
plasm. Counting was done by two observers (W.J. and F.H.),
without any knowledge of the diagnosis and the results of the
other observer's counts. All immunopositive cells were coun-
ted in at least 10 high-power fields (40 objective, 10
eyepiece) chosen at random. The numbers of positive cells in
ER, PR, IGF-1, and VEGF were given as a percentage for each
case. The percentages of positive cells examined were scored
as 0 points (0e5%), 1 point (6e24%), 2 points (25e49%), 3
points (50e74%), and 4 points (75e100%). Staining intensity
was graded as 0 points (negative), 1 point (weak), 2 points
(moderate), and 3 points (strong). The extent and location ofness of medical abortion with mifepristone and misoprostol, Journal of the
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were assessed according to the immunoreactive score by
multiplying the individual scores of extent by intensity.232.4. Real-time polymerase chain reactionRT-PCR determined the expression of IGF-1 and VEGF
mRNA. Total RNAwas extracted using Trizol reagent according
to the manufacturer's instructions (Invitrogen, Carlsbad, CA,
USA), and 4 mg was subjected to RT-PCR using the RevertAid
First Strand cDNA Synthesis Kit (Fermentas, Republic of
Lithuania) and the following primers: IGF-1: forward 5-
GCTGTGCCTGCTCACCTTC-3 and reverse 5-CCCTGTG
GGCTTGTTGAAAT-3; VEGF: forward 5-TTGCCTTGCTGC
TCTACCTC-3 and reverse 5-TGCATGGTGATGTTGGAC
TC-3. The cycling parameters for IGF-1 (35 cycles) and VEGF
(29 cycles) were as follows: denaturation (94C, 30 seconds),
annealing (62C, 30 seconds), and extension (72C, 30 seconds);
and denaturation (94C, 30 seconds), annealing (60C, 30 sec-
onds), and extension (72C, 30 seconds), respectively. All ex-
perimentswere performed in triplicate. The expression ofb-actin
in the same tissue was determined for the possibility of RNA
degradation or RNA transcription default. The PCR products
were electrophoresed and the sequence was analyzed.2.5. Statistical analysisStatistical analysis was performed using the SPSS version
16.0 package (Statistical Package for the Social Sciences Inc.,
Chicago, IL, USA). The data were expressed as mean ± -
standard deviation. Data were first subjected to the Kolmo-
goroveSmirnov test to confirm normal distribution and
Levene's test for analysis of variance. Two-sample t test was
used to compare age, gestational age, and IGF-1 and VEGF
proteins in each tissue between the two groups, which dis-
played a normal (Gaussian) distribution and homogeneity of
variance. The t test was used to evaluate any significant dif-
ference of IGF-1 and VEGF mRNA expression in each tissue
between the two groups, which displayed a normal distribution
and heterogeneity of variance. A p value < 0.05 was consid-
ered significant.
3. Results3.1. Demographic characteristicsOf the 68 women first included in this study, three expe-
rienced failure of the medical abortion method and two wereTable 1
Demographic characteristics of women undergoing medical abortion in the two gr
Group N Ages (y) Serum be
Complete abortion group 29 22.71± 2.24 5046± 19
Incomplete abortion group 34 23.53± 3.07 5587± 22
Values are shown as mean± SD.
hCG¼ human chorionic gonadotropin; SD¼ standard deviation.
Please cite this article in press as: Jiang W-X, et al., Factors related to complete
Chinese Medical Association (2016), http://dx.doi.org/10.1016/j.jcma.2016.03.01lost to follow-up. Therefore, this study ultimately included 63
women with early pregnancy who had requested medical
abortion, including 34 with incomplete medical abortion and
29 with complete medical abortion (Fig. 1). Overall, there was
no statistically significant difference in age, gestational age,
serum beta-human chorionic gonadotropin level, and body
mass index between the two groups (Table 1).3.2. Immunohistochemical resultsDecidual cells from early pregnancy showed the presence
of ER with stained nuclei; however, chorionic villus cells did
not express ER in either group. However, the negative control
group showed negative expression, and positive control group
leiomyoma and endometrium tissues strongly expressed ER in
nuclei. The expression of PR was similar to that of ER with no
expression of PR in villi in both the complete abortion group
and the incomplete abortion group.
IGF-1 immunostaining was found in chorionic villi cells in
the two groups, whose immunoreactivity was localized in the
cytoplasm (Figs. 2A, 2B, S1A, and S1B). In the incomplete
abortion group, IGF-1 expression was 4.27± 1.26, which
significantly decreased from that in the complete abortion
group (5.67 ± 2.28, p< 0.05; Fig. 2E).
Positive VEGF staining was detected in the cytoplasm of
chorionic villi cells in the two groups. In the incomplete
abortion group, VEGF immunostaining was strongly positive
in chorionic villi cells (Figs. 2D and S1D), while in the
complete abortion group, VEGF staining was weak (Figs. 2C
and S1C). The difference of VEGF expression between the
two groups was found to be statistically significant ( p< 0.05;
Fig. 2E).3.3. RT-PCR resultsIGF-1 mRNA expression and VEGF mRNA expression
were observed among the two groups by RT-PCR. Lower IGF-
1 mRNA expression, but higher VEGF mRNA expression,
occurred in the incomplete abortion group compared with the
complete abortion group (Table 2 and Fig. 2F); however, there
was no statistically significant difference between the two
groups either for IGF-1 mRNA expression or for VEGF
expression.
4. Discussion
This study investigated whether the levels of PR, ER,
VEGF, and IGF-1 in chorionic villi are related to completenessoups.
ta-hCG level (IU/L) Gestational age (d) Body mass index
67 37.71± 4.10 21.8± 1.5
39 39.24± 4.82 22.1± 1.3
ness of medical abortion with mifepristone and misoprostol, Journal of the
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Fig. 2. IGF-1 and VEGF expression in chorionic villi in the complete and incomplete abortion groups after medical abortion with mifepristone and misoprostol. (A)
The expression pattern of IGF-1 in the complete abortion group showed a high degree of brown staining in the cytoplasm of chorionic villi, suggesting high levels
of IGF-1 (magnification 400). (B) The expression pattern of IGF-1 in the incomplete abortion group showed some brown staining in the cytoplasm of chorionic
villi, suggesting lower levels of IGF-1 in this group (magnification 400). (C) The expression of pattern VEGF in the complete abortion group showed some brown
staining in the cytoplasm of chorionic villi, suggesting low levels of VEGF (magnification 400). (D) The expression pattern of VEGF in the incomplete abortion
group showed a high degree of brown staining in the cytoplasm of chorionic villi, suggesting higher levels of VEGF in this group (magnification 400). (E)
Quantification of the protein expression of VEGF and IGF-1 in both groups. (F) Quantification of the mRNA expression of VEGF and IGF-1 showed no significant
difference between the two groups. IGF-1¼ insulin-like growth factor; VEGF¼ vascular endothelial growth factor.
Table 2
Expression of IGF-1 and VEGF mRNA in the complete and incomplete
abortion groups.
N IGF-1 VEGF
Complete abortion 29 0.99± 0.34 0.99± 0.46
Incomplete abortion 34 1.01± 0.33 0.91± 0.27
p 0.652 0.363
Values are shown as mean± SD.
IGF-1¼ insulin-like growth factor; SD¼ standard deviation; VEGF¼ vas-
cular endothelial growth factor.
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Chinese Medical Association (2016), http://dx.doi.org/10.1016/j.jcma.2016.03.01of medical abortion. The results showed no expression of ER
and PR, but IGF-1 decreased and VEGF factor significantly
increased in the incomplete abortion group in comparison with
the complete abortion group. However, some bias to results
may be present as a low success rate of medical abortion
(29/63) was found compared with previous studies. This may
be because we selected those patients who had evacuated the
gestational sac from the vagina within 4 hours after miso-
prostol administration in order to use fresh tissue samples;
therefore, a proportion of the patients who needed longer than
4 hours for the discharge would not be evaluated in our study.
We need to estimate the overall abortion rate after 2 weeks,ness of medical abortion with mifepristone and misoprostol, Journal of the
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factors may also affect the successful abortion rate: gestational
age, parity, previous termination of pregnancy, initial serum
beta-human chorionic gonadotropin levels, different routes of
administration of misoprostol, and the time interval between
mifepristone and misoprostol administration.
Liu et al24 found that mifepristone regulated many genes and
pathways in chorionic villi in early pregnancy, using cDNA
microarray. Meanwhile, Abd-Elnaeim et al25 revealed that PR
and ER were detected in trophoblast cells, chorionic villous
stroma, microcaruncular epithelium, and microcaruncular
stroma in equine placenta. Meng et al26 found that ER and PR
were present in the nuclei of human first-trimester chorionic villi
exposed to postovulatory administration of 1.5 mg of levonor-
gestrel. Although inconsistent with the previous research, our
results indicated that PR and ER were not in chorionic villi in
either abortion group; however, without a comparison group of
women who underwent surgical abortion without prior admin-
istration ofmifepristone ormisoprostol, we cannot categorically
say that PR and ERwere not present. This is different fromwhat
was expected. Gligorijevic et al27 reported negative immuno-
histochemical results in the detection of ER and PR in the acinar
cells of the acrimal gland, postulating that the results are the
consequence of the affinity of antibodies used in the immuno-
histochemical procedure. However, in the present study, the
antibodies showed positive staining of ER and PR in decidual
tissues and in the positive control uterine leiomyoma tissue. The
postulated mechanism may be that, through binding to PR,
mifepristone may change the construction of PR or inhibit the
transformation of PR, resulting in its negative expression.
IGF-1 has been implicated as a potential regulatory factor
for reproduction and participates in many aspects of modu-
lating early term pregnancy. Our data revealed that IGF-1 was
expressed in the cytoplasm of chorionic villi cells in the two
groups, but had significantly higher expression in the incom-
plete abortion group. There are many cross-talk pathways
between estrogen and IGF at the molecular level in breast
cancer, and IGF-1 can upregulate ER.28,29 ER in chorionic villi
appears to be under the regulation of IGF-1, which can
upregulate the production and activity of ER in chorionic villi.
It is likely that the significantly low expression of IGF-1 in
incomplete medical abortion with mifepristone makes less
contribution to ER upregulation, which has the potential to
profoundly influence uterine contraction and shedding of
endometrial layers and chorionic villi, leading to incomplete
abortion.
As a key regulator of angiogenesis, VEGF is essential in
embryo development for regulating the extensive microvas-
cular net and early hematopoiesis in pregnancy. It was pro-
posed that cells with high expression of VEGF are
comparatively insensitive to mifepristone.30 Low doses of
mifepristone (2 mg or 5 mg daily) reduced stromal VEGF
protein expression, contributing to the development of amen-
orrhea,31 suggesting that mifepristone-induced amenorrhea is
associated with a decrease in stromal VEGF. In accordance
with these studies, our results also indicated that the VEGF
increases sharply in the incomplete abortion group comparedPlease cite this article in press as: Jiang W-X, et al., Factors related to complete
Chinese Medical Association (2016), http://dx.doi.org/10.1016/j.jcma.2016.03.01with that in the complete abortion group, and this occurs
almost exclusively in the cytoplasm of chorionic villi cells.
Except for its antiprogesterone action, mifepristone also acts
on endometrial blood vessels, causing vascular damage that
further compromises the embryo.32 Therefore, we postulate
that upregulation of VEGF expression by mifepristone is
associated with abnormal vascular formation, contributing to
uterine contraction and shedding of decidua and chorionic
villi. Thus, the increased expression of VEGF in chorionic villi
suggests incomplete abortion with mifepristone.
The significant difference between IGF-1 and VEGF pro-
tein expression was not seen at the mRNA expression level.
We presume that IGF-1 and VEGF activities can be regulated
post-transcriptionally, but this mechanism needs further study.
As a preliminary study, we made every effort to avoid
confounding factors that might have an impact on the results.
This included restricting the inclusion criteria to patients
younger than 30 years of age, and inclusion of only non-
smokers and primigravidae. However, owing to this restriction
of the study population, the results have less generalizability to
the overall population. Some of the patients did not agree to
provide blood samples, so we could not evaluate the influence
of hormones such as human chorionic gonadotropin, estrogen,
and progesterone on these results. Previous research has
shown an association of the success of medical abortion with
factors such as serum beta-human chorionic gonadotropin,
endometrial thickness, and body mass index,7,8,33,34 but we did
not compare these factors between the two groups. These
measurements are needed to be included in future studies. In
addition, the mean gestational age in days was higher in the
incomplete abortion group than in the complete abortion
group, which, although not statistically significant, might have
an influence on the analysis of VEGF and IGF-1, and which
might adjust with the gestational age; however, we consider
this unlikely, and so we did not adjust for it. Nonetheless, this
will need further investigation in the future.
In conclusion, our findings demonstrate that the expression
of IGF-1 and VEGF protein in chorionic villi is associated
with the outcome of medical abortion with mifepristone and
misoprostol. Whereas PR and ER expression in chorionic villi
is not related to the outcome of medical abortion, this suggests
a new direction for further study on the mechanism of
incomplete abortion with mifepristone and misoprostol, which
may provide methods to achieve complete medical abortion.
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